Biochemics sec

Author: kfeq

August undefined, 2024

WebGet free access to the complete judgment in Sec. & Exch. Comm'n v. BioChemics, Inc. on CaseMine. WebFeb 3, 2015 · § the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and § the SEC filed an enforcement action against Biochemics, Masiz, and two promoters...

Biochemics, Inc. - Company Profile - Corporation Wiki

WebDec 17, 2012 · Courthouse News Staff / December 17, 2012. BOSTON (CN) - An attorney duped investors for $9 million through his purported biopharma company, Biochemics, … WebBiochemists work in industries like agriculture, medical research, biotechnology and nutritional research. Our students go on to positions in research and industry, as well as graduate study in biochemistry, … slumbering worldsnail shell wow

Sec. & Exch. Comm

WebMar 4, 2024 · biochemistry, study of the chemical substances and processes that occur in plants, animals, and microorganisms and of the changes they undergo during … Webthe SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December 2012 (after the expiration of the policy period). Biochemics notified AXIS of the January and March 2012 subpoenas. WebAug 22, 2024 · According to the SEC complaint, BioChemics, Masiz and co-conspirators were accused of engaging in a fraudulent scheme to sell company securities to approximately 70 investors. The scheme, which ran from 2009 until the middle of 2012, netted at least $9 million. Investors caught up in the scheme resided in 19 different states. solar and wind power for homes

Biochemics, Inc. v. Axis Reinsurance Co.: When Does a …

Biochemistry - Wikipedia

WebIn 2015, the SEC won a $17.2 million judgment against BioChemics stemming from an allegation that BioChemics misled 70 investors by exaggerating the positive test results … WebThe relevant facts trace back to the SEC indictment of BioChemics and BioChemics’s CEO John Masiz for securities fraud in 2012. See SEC v. Biochemics, Inc., 435 F. Supp. 3d 281, 285 (D. Mass. 2024) (appeal dismissed as moot at SEC v. Masiz, No. 19-2206, No. 20-1177, No. 20- solar and wind intermittencyWebDec 16, 2012 · The SEC claims that in 2010 and 2011 BioChemics, Masiz, and Kroning misrepresented to investors and potential investors the status of research collaborations with other pharmaceutical companies: “For example, in 2010 and 2011, BioChemics published a multiple-page overview entitled Executive Summary (“Executive Summary”) that touted … slumber inn new minas nova scotia

"WebAug 7, 2013 · BioChemics is a specialty pharmaceutical company focused on transdermal drug delivery systems, including medicated lotions. Masiz is BioChemics's president and chief executive officer. In May 2011 and September 2011, the SEC served document subpoenas on BioChemics requesting a broad range of documents regarding the … " - Biochemics sec

Biochemics sec

BioChemics Claims It Can Pay Chunk Of $17M SEC Judgment

WebJan 17, 2024 · See SEC v. BioChemics, Inc. et al., No. 12-12324-MLW (D. Mass.). On 8/18/18 the Commission dismissed the claims against Masiz under Section 10 (b) of, and … Webbiochemistry: [noun] chemistry that deals with the chemical compounds and processes occurring in organisms.

Did you know?

WebLaw360, Boston (October 10, 2024, 5:10 PM EDT) -- After dodging a $17 million payment to the U.S. Securities and Exchange Commission, BioChemics Inc. will have to deal with a court-appointed... WebThe treatment that could produce the money for BioChemics to pay down its SEC debt is already being prescribed by doctors associated with “leading medical institutions,” Schlichtmann said. In addition to the $17.2 million BioChemics owes the SEC, Florida-based private equity firm ADEC Private

WebJan 6, 2015 · Plaintiffs BioChemics, Inc., and John Masiz sued defendant Axis Reinsurance Company (“AXIS”) for defense costs arising out of a Securities and Exchange Commission (“SEC”) investigation and enforcement action under their directors and officers (“D & O”) liability insurance policy. WebMar 25, 2015 · The judgment entered on March 25, 2015, supplements the March 18, 2015 judgment, and requires BioChemics to disgorge $15,105,325 in ill-gotten gains plus …

WebDec 14, 2012 · BioChemics of Danvers faces fraud charges By Beth Healy Globe Staff,December 14, 2012, 2:17 p.m. Federal securities regulators on Friday filed civil fraud charges against BioChemics Inc. of... WebAug 29, 2024 · According to the complaint, when BioChemics finally did conduct one clinical trial, it misrepresented the results of that trial. The complaint further alleged that Masiz …

WebMay 23, 2024 · Plaintiffs sought damages for what they claimed was AXIS's breach, under the relevant policy, of its duty to defend them in connection with an investigation conducted by the Securities and Exchange Commission against BioChemics and its officers.

WebBiochemistry or biological chemistry is the study of chemical processes within and relating to living organisms. A sub-discipline of both chemistry and biology, biochemistry may be divided into three fields: structural … slumber inn nova scotia slumbering traductionWebThe SEC claimed in a 2012 lawsuit that BioChemics and Masiz lied about the status of topical gels that would allow medicine to be absorbed through the skin. They allegedly falsely asserted the... slumbering wolf\\u0027s shack elden ringWebJun 24, 2024 · In BioChemics, Inc. v. AXIS Reinsurance Co., 2024 WL 2223125 (1st Cir. May 23, 2024), the United States Court of Appeals for the First Circuit held that a D&O policy did not provide coverage for an SEC … solar and wind power stocksWebSep 6, 2024 · In Biochemics, Inc. v. AXIS Reinsurance Company, 2024 WL 2223125 (1st Cir. 2024), the SEC issued a subpoena to Biochemics on May 5, 2011, requesting that Biochemics produce certain documentation in connection with the SEC’s investigation into whether Biochemics and its President and CEO, John Masiz, had committed securities … solar and wind powered carsWebDeveloper of transdermal drug delivery technology designed to offer treatment for the skin. slumbering with the enemy powerpuff girlsWebLaw360, Boston (September 11, 2024, 6:30 PM EDT) -- The U.S. Securities and Exchange Commission and a Massachusetts federal judge appeared skeptical Tuesday of BioChemics Inc.'s claims that it... slumber in spanish